QRM Capital

SentiAR, Inc. is a digital health company based in St. Louis, Missouri, focused on developing a 3D augmented reality holographic platform aimed at enhancing interventional medical procedures. Incorporated in 2017 and originating from Washington University, SentiAR's technology allows for real-time holographic visualization of a patient's anatomy and catheter positioning during procedures, utilizing data from various imaging modalities such as CT and MRI. This innovative platform is designed to create an interactive and controllable interface for clinicians, thereby improving the accuracy and safety of cardiac arrhythmia treatments. SentiAR's mission is to significantly enhance the experience for both patients and healthcare providers in catheter lab environments. The company is currently working towards obtaining FDA approval for its platform.

Healium is a company that specializes in providing drugless solutions for managing anxiety and sleep issues through immersive media experiences. Their technology integrates with fitness trackers and other sensors, such as smart watches or EEG meditation headbands, to create reactive video content driven by the user's brainwaves and heart rate. This approach allows users to control their bio-data displayed on the screen via hardware-agnostic sensors, offering a personalized experience that has been clinically validated in peer-reviewed journals to quickly reduce anxiety and improve mood within just four minutes.

Peptyde Bio is an Agtech startup focused on combating fungal diseases through innovative bio-fungicidal technology. The company specializes in developing natural antimicrobial peptides (AMPs) sourced from plants, which offer a cost-effective and efficient alternative for treating such diseases. By leveraging these natural compounds, Peptyde Bio aims to establish itself as a leading supplier of AMPs, providing effective solutions for agricultural challenges while promoting sustainable practices in crop protection.

Plastomics Inc. is a biotechnology company that specializes in chloroplast genetic engineering to enhance crop performance and nutritional quality. Founded in 2016 and based in Saint Louis, Missouri, the company utilizes a proprietary technology platform to insert beneficial traits into the chloroplasts of plant cells. This innovative approach allows seed companies to develop advanced biotech crops with a diverse array of traits while addressing current industry challenges. Plastomics' technology not only eliminates cross-pollination but also facilitates unique maternal inheritance, significantly reducing breeding timelines and associated costs. By focusing on gene stacking and rapid breeding, Plastomics aims to improve yield production and contribute to the advancement of agricultural biotechnology.